Company Filing History:
Years Active: 2018
Title: Glen Travers - Innovator in Gut Health
Introduction
Glen Travers is a notable inventor based in London, GB. He has made significant contributions to the field of gut health through his innovative research and inventions. His work focuses on preserving the integrity of peptides in the gut, which is crucial for various therapeutic applications.
Latest Patents
Glen Travers holds a patent titled "Bile acids and biguanides as protease inhibitors for preserving the integrity of peptides in the gut." This invention relates to methods of preserving the integrity of peptides in the gut. In particular, it concerns the use of certain compounds as inhibitors of gut proteases. Compounds identified as having gut protease inhibitory activity include biguanides, certain bile acids, and pharmaceutically acceptable salts of these compounds. This activity makes these compounds useful for co-administration with prophylactic or therapeutic peptides. The invention also relates to methods of inhibiting gut proteases and peptide formulations comprising these gut protease inhibitors. He has 1 patent to his name.
Career Highlights
Glen Travers is currently associated with Axcess, Inc., where he continues to develop innovative solutions in the field of gut health. His work has garnered attention for its potential impact on therapeutic practices.
Collaborations
Glen collaborates with Roger R C New, who is also involved in similar research areas. Their combined expertise contributes to advancements in gut health and peptide integrity.
Conclusion
Glen Travers is a pioneering inventor whose work on gut protease inhibitors has the potential to revolutionize therapeutic approaches in gut health. His contributions are significant in the ongoing quest for effective treatments.